Observational study comprising prospective follow up as well as retrospective chart review in order to evaluate the longitudinal course of the disease in XLH patients with a specific focus on functional impairment, physical performance and complications associated with the disease or respective treatment.
This is an observational / non-interventional study in order to assess the longitudinal course of XLH including disease related burden of disease and functional impairment. This is accomplished by both prospective follow up of affected patients as well as retrospective chart review. Evaluation conducted as per clincal routine and specifically evaluated as part of this study will include * baseline documententation / demographic (as obtained from medical records) * general data on XLH-disease specific medical history * physical examination results * functional assessments * technical assessments * quality of life / questionnaires * laboratory evaluations
Study Type
OBSERVATIONAL
Enrollment
60
no intervention
Orthopedic Center for Musculoskeletal Research, Orthopedic Department, University of Wuerzburg
Würzburg, Germany
Course of disease
To document and assess the natural course of disease, associated symptoms and functional impairment in adult patients with XLH.
Time frame: retrospective and up to 48 months from enrollment
Comorbidities and medical treatment
Assess and document comorbidities and medical treatment regimens applied in adult patients with XLH
Time frame: retrospective and up to 48 months from enrollment
Functional deficits and mobility constraints
Assess and document functional deficits and mobility constraints in adult patients with XLH
Time frame: retrospective and up to 48 months from enrollment
Laboratory values
Assess laboratory parameters over time in adults with XLH
Time frame: retrospective and up to 48 months from enrollment
Organ / tissue specific health issues
Describe frequency and outcome of organ / tissue specific health issues (affecting e.g. skeleton, dental health, muscles and joints) in adults with XLH
Time frame: retrospective and up to 48 months from enrollment
Safety and tolerability of treatment
Evaluate safety and tolerability of various treatment regimens commonly applied in XLH patients
Time frame: retrospective and up to 48 months from enrollment
Quality of life
Assess quality of life and respective determining factors in adults patients with XLH
Time frame: retrospective and up to 48 months from enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.